Latest Headlines

  1. Genetic Testing Pioneer DnaNudge Signs Key Agreement With Spain’s Largest Clinical Group Quirónprevención 9/7/2021

    Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.

  2. Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection Of DNA Or RNA From Saliva Samples 9/7/2021

    Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its new Air-Dryable™ Direct DNA qPCR Saliva and Air-Dryable™ Direct RNA/DNA qPCR Saliva Mixes, which are designed for incorporation in room-temperature stable molecular assays, directly targeting nucleic acid sequence from saliva and sputum.

  3. NuProbe Global Adopts Bionano’s Saphyr® System To Develop Products In Reproductive Health And Oncology Applications 9/7/2021

    Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies for research and product development in the fields of reproductive health and oncology liquid biopsies.

  4. LexaGene’s MiQLab™ Accurately Detects Multiple Strains Of Pathogenic Bacteria In Polymicrobial Samples Compared To Conventional Culture 9/7/2021

    LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced it successfully utilized its MiQLab™ System (“MiQLab”) to detect the presence of multiple strains of pathogenic bacteria in polymicrobial samples that vary in their antimicrobial resistance (AMR).

  5. BGI's COVID-19 Test Laboratory At The Airport Secures Route Between Ethiopia And China 9/6/2021

    From April to August 2021 , the BGI's COVID-19 testing lab helped 5,500 Chinese travelers fly safely from Addis Ababa Bole International Airport. In April, the BGI, in cooperation with Ethiopia Airlines, set up the "Huo-Yan" laboratory, a COVID-19 test laboratory, at the airport for passengers flying to China only flight was suspended.

  6. Home Blood Collection Device Works For COVID Antibody Test 9/3/2021

    A device that could make it possible for patients to draw their own blood at home was successfully used to collect blood samples for measuring antibodies against SARS-CoV-2, the virus that causes COVID-19, researchers at the University of Washington School of Medicine in Seattle report.

  7. NuProbe Global And Bionano To Co-Develop Products In Reproductive Health And Oncology Testing 9/1/2021

    NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, and Bionano Genomics, based in San Diego, California, have entered into a procurement and collaboration agreement, where NuProbe will integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies with Bionano's Saphyr system for research and product development in the fields of reproductive health and oncology liquid biopsies.

  8. Todos Medical’s CLIA/CAP Lab Provista Completes Validation Of Combination COVID, Influenza A & B, RSV & hMPV Respiratory Panel Test 9/1/2021

    Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP certified lab Provista Diagnostics has successfully completed the validation studies required to put the Quidel Lyra Influenza A & B and the Lyra RSV & hMPV PCR kits into production alongside COVID PCR tests currently being run (together the “Provista Respiratory Panel”) and expects this new respiratory panel to be launched in September 2021.

  9. Natera Announces The Validation And Launch Of The Prospera™ Heart Transplant Assessment Test 8/31/2021

    Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, today announced the validation and clinical availability of its Prospera Heart transplant assessment test for heart transplant recipients.

  10. BC Platforms Launches Packaged End-To-End Solution For NGS Laboratories With Sentieon To Accelerate Adoption Of NGS Testing 8/31/2021

    BC Platforms (BCP), a global leader in healthcare data management and analytics and US-based Sentieon, a developer of highly optimized algorithms for bioinformatics applications, today announced the launch of its new integrated next generation sequencing (NGS) genetic analytics software, known as BC|GENOME X-10.